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Abstract 
Objective: This paper presents normal reference values for thermal sensation for a study population 
with no known neurological condition in northern India.  It was part of the INFIR Cohort Study, a 
prospective study of people newly diagnosed with multibacillary leprosy, the objective being to identify 
early changes in nerve function predictive of new onset impairment and reactions. Methods: Data on 
warm and cold sensation in fi ve bilateral nerves was collected from 326 healthy subjects stratifi ed by 
sex and by age and drawn from the same general population as the subsequent leprosy-affected cohort. 
Reference values were computed from log-transformed data after the exclusion of outliers. Results: 
Normal reference values are presented in the form of 95th percentiles for warm and 5th percentile 
for cold sensation within eight age and sex groups and by centre. The prevalence of impairment at 
diagnosis among the leprosy-affected cohort is described and illustrated The high prevalence of lost 
warm sensation in the leprosy-affected cohort suggests that this is an important early indicator for 
nerve involvement in leprosy. 
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INTRODUCTION
Monitoring nerve function provides essential 
information in assessing the needs of individuals 
at risk of peripheral neuropathy.1 Rigorous 
clinical evaluation involves assessing the ability 
to detect sensation of vibration, warm and cold 
temperature and other stimuli, collectively known 
as Quantitative Sensation Testing (QST). While 
these methods have been widely applied for use 
in diabetic patients, only limited use has been 
made in the context of leprosy.2  
 Thermal Sensation Assessment (TSA) has been 
demonstrated to be sensitive to abnormalities in the 
small fi bres of thin myelinated and unmyelinated 
nerves, by cold and warm temperature threshold 
testing respectively.3,4 Deterioration in temperature 
thresholds refl ects changes in nerve status and is an 
indicator for small fi bre damage. In combination 
with other assessments it supports the diagnosis of 
the presence and extent of neuropathy. Compared 
to other technical tests such as nerve conduction, 
TSA is simple to perform and gives readily 
interpretable results on the functional status of the 
peripheral nerves.5 It has potential applications in 
a number of conditions, for example, a northern 
India study on detecting small fi bre neuropathy.6 
A cross-sectional study in Brazil found extreme 
warm and cold sensation thresholds in the skin 
lesions of 112 individuals newly diagnosed with 
leprosy.7 In the case of leprosy, loss of sensation 
may occur prior to and during treatment with 
multi-drug therapy with an increased risk of 
secondary impairments.  Identifying the early 
indicators of nerve involvement is therefore a 
primary concern. 
 Accurate determination of the limits of normal 
function requires the collection and analysis 
of data from healthy, non-neuropathic subjects 
drawn from a study population within a defi ned 
geographical area.11 The purpose of the present 
study was to compute normal reference values 
within appropriate age and sex groups in a 
study population in Uttar Pradesh State, northern 
India for which no reference data has previously 
been published. The resulting reference values 
were then applied to classify nerve function in 
a prospective cohort study of newly diagnosed 
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multibacillary leprosy, the INFIR Cohort Study, 
the objective being to identify early changes in 
nerve function predictive of new onset impairment 
and reactions. See the fi rst paper of the present 
series12 for more details.  
METHODS 
Equipment
The equipment used in each field centre 
was a Thermal Sensation Analyser (TSA) II 
manufactured by Medoc, Israel and supported 
and maintained by agents in India. The TSA II 
is a computer-linked system that heats or cools a 
thermode. Starting from a baseline temperature of 
32˚C it allows determination of thermal sensation 
thresholds by a stepwise warming or cooling of 
the thermode placed in turn on each of a series 
of test sites. Subjects indicate when they perceive 
a change in temperature. The equipment records 
the appropriate temperature as the limit of 
warm or cold sensation alongside demographic 
data in a standard spreadsheet format. Several 
different algorithms are available for determining 
thresholds, including the ‘forced-choice, two-
alternative method’, the ‘method of limits’ and 
the ‘method of levels’.5 Since the method of levels 
has good test repeatability and little inter-session 
bias compared to the other methods.13  this was 
the preferred method for the present study. 
Subject selection and sample size
As with the study of vibration thresholds we 
planned to recruit subjects from among the healthy 
relatives accompanying individuals attending 
general and dermatology outpatient clinics at the 
two participating centres, applying inclusion and 
exclusion criteria as follows:
Inclusion criteria: Individuals were selected 
to obtain an equal number of male and female 
subjects and equal numbers of subjects in each of 
four age bands up to 60 years, the maximum age 
for recruitment to the subsequent cohort study. 
Exclusion criteria: Since the diagnosis of leprosy 
can only be made on clinical grounds all subjects 
were screened by an experienced leprologist 
leading to the exclusion of anyone exhibiting 
clinical signs or symptoms of leprosy.  Subjects 
with any known neurological disorder, previous 
contact with leprosy or a history of diabetes were 
also excluded.  Individuals aged above 60 years 
or those less than 10 years were excluded.
 To ensure adequate precision we planned to 
assess 40 subjects within each of the four age 
groups for men and for women. The overall 
target for the number of normal subjects was 
therefore 320, equal numbers to be recruited in 
each centre.  
Protocol for testing and data recording
The test sites and bilateral nerves assessed in 
the study were the same as those to be assessed 
in the Cohort Study. These were the cutaneous 
areas innervated by fi ve of the nerves commonly 
affected during leprosy neuropathy. For the ulnar 
nerve, the palmar hypothenar area, for the median, 
the palmar thenar area, for the radial cutaneous, 
the dorso-radial web space between the thumb and 
the fi rst digit, for the sural, the dorso-lateral area 
of the foot and for the posterior tibial nerve, the 
plantar surface of the distal phalanx of the big toe. 
At each site cold and warm sensation thresholds 
were assessed, giving a total of 20 data points 
for each subject. The test procedure is outlined 
in Table 1. Further details on the study design are 
available in an earlier publication.8 
  Producing reliable data requires good levels of 
concentration on the part of subjects.  Subjects 
were informed of the testing process and given 
practice in responding to the thermal stimulus. 
Verbal encouragement and instructions were 
given throughout the procedure. A small number 
of subjects were unable to detect warming at 
temperatures approaching 50ºC or cooling at 
temperatures approaching 10ºC, the range of 
measurable temperatures. All these assessments 
were excluded from the calculation of reference 
values. 
 The testing was undertaken by a team of 
physiotherapists also responsible for vibrometry 
and nerve conduction testing. After initial training 
the teams in each centre, four physiotherapists 
and a physio-technician in Naini and four 
physiotherapists in Faizabad, completed inter-rater 
reliability testing. Within each centre each pairing 
was asked to complete up to 20 assessments of 
volunteer subjects. For this purpose only we 
recruited subjects with a variety of neurological 
conditions that would ensure testing across a 
range of warm and cold sensation thresholds. The 
results were analysed and demonstrated a good 
level of reliability.
Identifi cation of outliers and computation of 
reference values
A total of 326 subjects were assessed and the 
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Procedure for thermal sensation testing
At the start of the day:
 1. Switch on the TSA unit after the computer has completed the boot process. 
 2. Check the water level in the TSA unit, add distilled water if necessary.
 3. Start the TSA software.  The computer communicates with the unit in ‘real-time’ and so expects 
continuous feed-back from the unit.
 4. Wait for 30 seconds for the system to initialise. The thermode and water temperature are reported 
in real-time in the top right-hand corner of the screen.
 5. Ensure that “Device” is set to thermal 
To perform a test:
 1. The subject should be seated in front of the examiner in a relaxed position.  Explain the procedure 
to the subject, including the type of sensation (s)he will be experiencing. Let him/her feel the 
thermode surface.
 2. Click once on the large ‘Test’ button or press Alt-t. 
 3. Click  ‘Open departments or directories’.  Select the folder  for data storage (Faizabad or Naini).
 4. For new subjects click Add and enter demographic data.  Click OK.  Select existing subjects from 
list.
 5. The system will automatically select the algorithm that uses the “Levels” method.  
 6. Either, click Level 5 for warm sensation testing or Level 6 for cold sensation testing.
 7. Proceed through the testing fi rst warm and then cold sensation at each site on 5 bilateral nerves 
using the following procedure:
  7.1 Select a test site from the list and click Continue
  7.2 Strap the thermode to the selected site making sure that it stays in place until testing on that 
site is complete.  Hold the response button in your left hand.
  7.3 For the method of levels: Tell the subject that a warm (or cold) stimulus will be given, followed 
by an audible sound. Tell him/her that you will be asking him/her whether (s)he felt the stimulus 
or not, after the sound. A ‘don’t know’ response will be interpreted as a ‘No’. Run one trial 
series to familiarise the person with the procedure. This may only be necessary the fi rst one 
or two times the person comes for testing.
  7.4 Alert the subject that you are about to begin with testing. Press the space bar to start the test. 
After a count-down of 4 seconds, the fi rst stimulus will appear. A tone-sound can be heard 
when the maximum has been reached. There is a brief pause while the temperature returns to 
baseline.
  7.5 When using the method of levels, a prompt appears: “Use Y/N keys or Patient Response Unit”. 
At this point, ask the subject: “Did you feel this, yes or no?” Indicate the response using the 
corresponding key on the keyboard or the corresponding mouse button. As soon as you have 
done this, the count-down for the next stimulus starts.
  7.6 Repeat 9.4 and 9.5 until a blue bar appears indicating that the threshold has been determined. 
(See Figure 1.)
 8. Click ‘Save’ to save the results of the warm sensation test at the current site. 
 9. Repeat the process for cold sensation at the same site (Return to point 6, above.)
 10. Repeat for each of the fi ve bilateral nerves.
 11. Finally fi le a printout of the results.
 12. At the end of the working day make a back-up of the saved data.
Table 1:  Instructions for thermal sensation testing
data from the resulting spreadsheets merged into 
a single spreadsheet. Since the data collection 
procedure was fully automated data checking 
focussed on the accuracy of demographic data 
and the availability of data from all subjects 
assessed.
 As with the analysis relating to reference values 
for vibration perception12, we identifi ed outliers 
using regression analysis of log-transformed 
warm and cold sensation data on age. In view of 
differences between centres as well as between 
sexes these analyses were repeated within four 
groups defi ned by centre and sex.  Any assessments 
for which the standardised residual exceeded 2.58 
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were identifi ed as outliers and excluded from all 
further analysis. Where a subject was found with 
3 or more outliers all assessments were excluded. 
The same process was repeated to exclude further 
suspect outliers.  We then used analysis of variance 
to assess differences between sexes, between age 
groups, between left and right sides and between 
centres.  
 In the absence of differences between left and 
right side assessments we planned to pool the 
remaining assessments, effectively doubling the 
sample size and then used regression analysis 
of log transformed data on age within each sex 
and centre grouping to compute reference values. 
These were reverse-transformed to the original 
units of temperature (˚C). Presented here are 
reference values based on 95th percentiles for 
reduced warm and 5th percentile for reduced cold 
sensation in each of the fi ve sites tested. Details of 
97.5th /2.5th and 99th /1st percentiles are available 
from the authors. 
 All the analysis was carried out using 
STATA.   
Application of reference values
The reference values were then applied to 
classify nerve function among the 303 cases 
newly diagnosed with multibacillary leprosy 
and recruited to the prospective INFIR Cohort 
Study, the objective being to identify early 
changes in nerve function predictive of new onset 
impairment and reactions. Other papers in the 
present series12,14 describe reference values for 
vibration perception thresholds and for parameters 
of sensory and motor nerve conduction. The fi rst 
of these provides more information on the cohort 
study and references to other published work. The 
reference values reported here are based on a re-
analysis of the normative data using methods that 
show greater sensitivity to differences relating to 
sex, age and centre.  
Ethical Approval
Permission for all aspects of the INFIR study 
was obtained from the Indian Council of Medical 
Research. The Research Ethics Committee of the 
Central JALMA Institute for Leprosy in Agra gave 
ethical approval. Written consent was obtained 
from cases before enrolment in the Cohort Study 
and verbal consent from subjects participating in 
the normative study. 
RESULTS
A total of 326 subjects were enrolled during the 
study period ending in July 2001. The fi rst round 
of outlier identifi cation resulted in the exclusion 
of 10 ulnar nerve assessments (5 warm and 5 
cold), 8 median nerve assessments (4, 4), 9 radial 
cutaneous nerve assessments (4, 5), 2 posterior 
tibial nerve assessments (0, 2) and 8 sural nerve 
assessments (1, 7). Three of the 23 subjects 
involved had three or more outliers and were 
eliminated from all further analyses. Other outliers 
were reset as missing values. In the second round, 
a further 16 subjects were identifi ed with one or 
more outliers. In total, 2.2% of all assessments 
were identifi ed as outliers and excluded from any 
further analysis. 
 Demographic data on subjects remaining in the 
analysis is presented in Table 2. The mean age 
for men and women in Faizabad were 39.2 years 
(standard deviation 13.4) and 39.9 years (13.7) 
respectively and in Naini 39.5 years (13.2) and 
38.8 years (12.3).   
 Summary statistics for warm and cold sensation 
are summarised by centre, in Tables 3A and 3B. 
The variability in numbers is caused by eliminated 
or missed assessments.   
 It is apparent from Table 3 that for each site 
mean values for warm sensation thresholds for 
Faizabad were marginally higher than those 
for Naini while mean cold sensation thresholds 
were marginally lower. For each test site and 
modality we used analysis of variance to assess 
the statistical signifi cance of effects relating to age, 
sex, side and centre.  The oldest age group had the 
highest value for warm sensation and the lowest 
value for cold sensation for each site (p<0.001). 
We found statistically signifi cant differences 
between sexes for palmar hypothenar warm 
and cold sensation and for palmar thenar warm 
sensation (p<0.05 for each). The importance of 
age-related trends and differences between sexes 
is evident from Figure 1. There were statistically 
signifi cant differences between left and right side 
only for the foot dorso-lateral test site (p<0.001 
for both warm and cold sensation). No interaction 
effects reached statistical signifi cance. Including 
centre in each of the analysis did not affect any 
of the fi ndings above. However, between centre 
differences reached statistical signifi cance in 
both warm and cold assessments at all fi ve sites 
(p<0.001).  
 We decided that the small differences in left 
and right side sural nerve functions, though 
statistically signifi cant, were too small to be of 
clinical signifi cance and therefore proceeded with 
calculation of reference values based on pooled 
left and right side assessments. The resulting 
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reference values based on the appropriate 95th 
or 5th percentile are presented in Table 4, broken 
down by sex and age group and by centre and 
for combined centres. 
 The strength of association with age, sex and 
centre is evident in the trends in reference values 
for both warm and cold sensation thresholds 
in Table 4. This is reinforced in Figure 1 
which presents scatter plots for hand and foot 
assessments overwritten with the appropriate 95th 
or 5th percentiles based on data from combined 
centres plus a shaded area illustrating the distance 
between centre-specifi c reference values.
 The scatter plots for plantar surface of the 
distal phalanx draw attention to the lack of 
sensitivity at the big toe. With increasing age 
the site becomes increasingly insensitive, some 
subjects being unable to detect warming to 
50˚C, the upper limit of the TSA equipment. A 
similar trend was found in cold sensation where 
the ability to detect cooling approach the lower 
10ºC limit. The scatter plots also draw attention 
to the differences between men and women and 
the lower levels of variability in the hand palmar 
hypothenar, compared to the great toe.  
 We applied these reference values to assess 
the nerve status of the 303 cases newly diagnosed 
with MB leprosy and recruited to the INFIR cohort 
study at the same two fi eld centres. Centre, age, 
sex and nerve-specifi c rates for impaired function 
beyond these reference values at time of diagnosis 
are presented in Table 5. More details of the cohort 
have already been published.8,9
 The scatter plots presented in Figure 2 illustrate 
the extent of impaired function found in the ulnar 
nerves of the leprosy cohort. We note that the rate 
of impairment in warm sensation exceeds that in 
cold sensation, suggesting that, in leprosy, warm 
sensation is affected earlier than cold. The same 
was true of the median, radial cutaneous and sural 
nerves. (Details available from authors).  
DISCUSSION
Thermal sensation assessment provides a unique 
functional measurement in the monitoring of 
peripheral nerve function. This is the fi rst major 
study to produce reference values for warm and 
cold sensation for a study population drawn from 
Uttar Pradesh state in northern India. The strength 
Faizabad
Age groups (years)
 Sex <=30 yrs 31-40 yrs 41-50 yrs 51-60 yrs Total
 
 Female  20 19 20 20 79
  25.3, 52.6 24.1, 45.2 25.3, 52.6 25.3, 51.3 50.3
 Male 18 23 18 19 78
  23.0, 47.4 29.5, 54.8 23.0, 47.4 24.4, 48.7 49.7
 Total 38 42 38 39 157
  24.2 26.8 24.2 24.8 
Naini
Age groups (years)
 Sex <=30 yrs 31-40 yrs 41-50 yrs 51-60 yrs Total
 
 Female  22 20 23 16 81
  27.2, 52.4 24.7, 48.8 28.4, 51.1 19.8, 44.4 49.4
 Male 20 21 22 20 84
  24.1, 47.6 25.3, 51.2 26.5, 48.9 24.1, 55.6 50.6
 Total 42 41 45 36 164
  25.6 25.0 27.4 22.0 
Table 2: Age and sex distribution plus row and column percentages for subjects assessed in two centres
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Figure 1. Scatter plot of ulnar and posterior tibial warm and cold sensation (degrees centrigrade) for normal 
subjects by age and by centre with 95th or 5th percentiles based on combined centres plus shaded area 
highlighting the difference between centre-specifi c percentiles. 
Chart 1C Chart 1D
Chart 1E Chart 1F
Chart 1G Chart 1H
Chart 1A Chart 1B
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 Ulnar Median Rad. Cut. Pos. Tib. Sural 
 Warm Cold Warm Cold Warm Cold Warm Cold Warm Cold
 M F M F M F M F M F M F M F M F M F M F 
Faizabad
 25.8 20.5 14.6 9.2 29.8 36.4 14.8 13.6 35.0 34.1 20.4 38.6 58.2 50.6 40.8 32.2 45.2 39.8 30.6 36.4 
Naini
 17.7 26.3 10.3 13.2 18.5 34.2 12.5 19.7 40.9 50.7 34.8 36.0 53.7 44.7 42.1 34.2 39.3 37.3 40.2 38.7 
Combined Centres
 21.7 23.8 10.5 10.4 22.8 34.8 12.6 11.6 37.0 41.7 25.6 36.8 50.6 44.8 37.5 30.7 42.7 38.7 32.7 33.7
of the study is its large sample size, allowing 
calculation of normal reference values stratifi ed 
by age, by sex and by centre for fi ve bilateral 
nerve sites. Our inclusion and exclusion criteria 
mean that the resulting reference values may be 
applied in similar areas of India. They may also be 
applied in studying the impact of other conditions 
in which warm and cold sensation are affected, 
specifi cally in diabetes.
 The first paper in the present series12 
discussed the impact of uncertainty about age 
on vibration perception thresholds. A tendency 
to underestimate age may be partly responsible 
for the extreme values identifi ed for warm and 
cold sensation thresholds in the present data set. 
However, the data for the lateral dorsum of the 
foot exhibit the most extreme values and greatest 
variability (Table 3A and 3B and Figure 1) and 
raise concerns about the sensitivity of testing 
when thresholds are close to the maximum 
measurable temperatures. Inability to detect such 
high temperatures also gives rise to concerns about 
the potential for damage to skin through testing. 
However, in none of the subjects or cases tested 
did we see any such damage.
 Given the vulnerability of the sole of the foot 
to injury, maintaining sensation in the foot is a 
primary concern in preventing secondary injury 
in leprosy. A study by Withington et al9 found 
the onset of disabilities in leprosy to be related to 
socio-economic factors and manual occupations. 
Such factors may well contribute to the variability 
in thresholds reported here.  
 While normal thresholds for the posterior 
tibial nerve are close to the limits of what 
could be tested, those for the sural nerve were 
less extreme. Testing sural nerve function may 
therefore be preferred.  However, the pattern of 
onset in nerve function impairment in leprosy is 
not well understood. Further analysis is therefore 
required to determine sensitivity and specifi city 
between the two nerves. 
 Working in Israel Yarnitsky and Sprecher10 
used the same Medoc Thermal Sensation 
Analyser to assess warm and cold sensation at 
the thenar eminence of the hand in a group of 
106 normal subjects. Using the method of levels 
they computed reference values using the 97.5th 
percentiles for warm sensation at the thenar 
eminence ranging from 32.5˚C in the age group 
20 - 39 years and 32.6˚C in the age group 60 to 
79 years. The equivalent for cold sensation was 
31.3˚C to 31.2˚C. In the present study we found 
both warm and cold sensation thresholds based 
on the less demanding 95th percentile to be more 
extreme- 34.0-.7 and 30.3-29.7 respectively. These 
fi ndings confi rm the importance of determining 
population-specifi c reference values.  
 Researchers in UK14 compared thermal 
sensation thresholds of healthy subjects in centres 
in Sweden, Belgium and UK in order to determine 
the causes of variability within their data. They 
found differences relating to occupation, age-
related effects and a skin temperature effect but 
no signifi cant difference between left and right 
side assessments. Compared to workers of other 
vocations, manual labourers were less able to 
detect temperature decrease and displayed a 
wider range between detectable warm and cold 
sensation. We did not record data on occupation 
Table 5: Impairment rates (percentages) for warm and cold sensation in five nerves among 303 newly 
diagnosed cases of multibacillary leprosy, presented by sex, by centre and for combined 
centres. 
37
Figure 2. Scatter plot of ulnar and posterior tibial warm and cold sensation (degrees centigrade) for leprosy cohort 
cases by age and by centre with superimposed normal 95th or 5th percentiles based on combined centres 
plus shaded area highlighting the difference between centre-specifi c percentiles. 
Chart 2A Chart 2B
Chart 2C Chart 2D
Chart 2E Chart 2F
Chart 2G Chart 2H
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for the subjects in the present study so are unable 
to comment on the effect of occupation. Since 
the observed difference between centres reached 
statistical signifi cance we decided to apply centre-
specifi c thresholds in our analysis of the cohort 
data. 
 In conclusion, this is the fi rst published study 
presenting reference values for warm and cold 
sensation among men and women and by age 
group in a study population in UP State, northern 
India. Subject to issues relating to assessments of 
the foot lateral dorsum, the results are of value in 
the assessment of nerve function in a wide range 
of neurological conditions.  
 Applying the reference values to data from 
the leprosy cohort illustrates the high rates of 
impaired function among people affected by 
leprosy. Further analysis of data from the Cohort 
Study will determine if detecting change in warm 
or cold sensation during multi-drug therapy is an 
indicator for the onset of clinical changes in nerve 
function associated with leprosy reactions.
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